The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs as a strategy to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. From Wikipedia
New research suggests nucleoside reverse transcriptase inhibitors may reduce Alzheimer’s risk by up to 13% annually, with trials planned to confirm their potential and test a safer derivative drug.
